Existing drugs could benefit patients with bone cancer, genetic study suggests
Friday, June 23, 2017 - 10:32
in Biology & Nature
A subgroup of patients with osteosarcoma -- a form of bone cancer -- could be helped by an existing drug, suggest scientists. In the largest genetic sequencing study of osteosarcoma to date, scientists discovered that 10 percent of patients with a genetic mutation in particular growth factor signalling genes may benefit from existing drugs, known as IGF1R inhibitors.